Investor Roundtable
London
Approved Investors Only
Sep
29
September 29, 2026
2:30 pm – 5:30 pm
Register to Get Link
Register to See Address
London
Join us for an intimate investor roundtable with the FVE Foundry GPs to explore a differentiated approach to life sciences investing and active opportunities across neurodegeneration, vaccines, antimicrobial resistance, and cellular aging.
Traditional life sciences venture funds often rely on a handful of outsized winners, with long hold periods and delayed distributions. FVE Foundry https://www.formationve.com takes a different approach. FVE Foundry sources overlooked, de-risked innovations globally and builds them into spinouts targeting major unmet health needs.
Investors receive 20% founding equity in every spinout, pay no carried interest, retain pro rata rights to invest directly at early valuations, and receive distributions at each liquidity event—creating greater alignment, flexibility, and direct exposure than a traditional venture fund structure.
We understand that the current situation in the region may raise questions for some attendees. The safety and wellbeing of our speakers, partners, and attendees remains our highest priority.
We are closely monitoring developments and remain in ongoing dialogue with relevant local partners. At this time, the VNTR Dubai Investor Forum is planned to proceed as scheduled, and preparations continue as normal.
We encourage participants to review official travel guidance from their respective governments and make decisions based on their own circumstances. Should anything change, we will communicate updates promptly.
We are closely monitoring developments and remain in ongoing dialogue with relevant local partners. At this time, the VNTR Dubai Investor Forum is planned to proceed as scheduled, and preparations continue as normal.
We encourage participants to review official travel guidance from their respective governments and make decisions based on their own circumstances. Should anything change, we will communicate updates promptly.























